Cite
HARVARD Citation
Park, I. et al. (2020). Gemcitabine plus carboplatin versus gemcitabine plus oxaliplatin in cisplatin-unfit patients with advanced urothelial carcinoma: a randomised phase II study (COACH, KCSG GU10-16). European journal of cancer. pp. 183-190. [Online].